Akt may drive TCA cycle flux and lipid biosynthesis by directly phosphorylating and activating ATP-citrate lyase, which protects tumor cells against chemotherapy drugs toxicity (Robey and Hay, 2009). Here, AKT1 is linked to neoplasm.